For those babies who do need opioids, can clinicians get them off the medications earlier? Is it safe to do so? What are the long-term consequences?

Understanding the Context

ACT NOW Weaning Randomized Clinical Trial What happens to these babies in the long term? To what extent is NOWS associated with atypical neurodevelopmental outcomes? ACT NOW Longitudinal Cohort Study MedPage Today: As Insurers Struggle With GLP-1 Drug Costs, Some Seek to Wean Patients Off After losing 50 pounds on the injectable weight loss medication tirzepatide (Zepbound), Kyra Wensley received a surprising letter from her pharmacy benefit manager in April. Her request for coverage ...

Key Insights

As Insurers Struggle With GLP-1 Drug Costs, Some Seek to Wean Patients Off AOL: How long does tirzepatide for weight loss stay in your system? Reviewed by Lynn Marie Morski, MD, JD. Tirzepatide (Mounjaro®, Zepbound®) is a once-weekly injection for type 2 diabetes and obesity. Since you only take it once a week, you know it’s at least ... The New England Journal of Medicine: Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes Tirzepatide, a dual incretin agonist of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, has favorable effects on glycemic control and body weight.

Final Thoughts

The effects ...